Alzheimer Drug Trials: Combination of Safe and Efficacious Biologicals to Break the Amyloidosis-Neuroinflammation Vicious Cycle

Overview

Journal ASN Neuro

Specialties Chemistry
Neurology

Date 2020 Apr 16

PMID 32290675

Authors

Tamas Bartfai

Graham V Lees

Affiliations

Soon will be listed here.

References

Niculescu A, Le-Niculescu H, Roseberry K, Wang S, Hart J, Kaur A . Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs. Mol Psychiatry. 2019; 25(8):1651-1672. PMC: 7387316. DOI: 10.1038/s41380-019-0602-2. View

Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

Orr M, Sullivan A, Frost B . A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies. Trends Pharmacol Sci. 2017; 38(7):637-648. PMC: 5476494. DOI: 10.1016/j.tips.2017.03.011. View

De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, Frenkel J, Hoffman H . Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. N Engl J Med. 2018; 378(20):1908-1919. DOI: 10.1056/NEJMoa1706314. View

Kahlenberg J . Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockade. Curr Opin Rheumatol. 2016; 28(3):197-203. PMC: 4901309. DOI: 10.1097/BOR.0000000000000266. View

Dong Y, Li X, Cheng J, Hou L . Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?. Int J Mol Sci. 2019; 20(3). PMC: 6386861. DOI: 10.3390/ijms20030558. View

Sevigny J, Chiao P, Bussiere T, Weinreb P, Williams L, Maier M . The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 2016; 537(7618):50-6. DOI: 10.1038/nature19323. View

Hampel H, OBryant S, Molinuevo J, Zetterberg H, Masters C, Lista S . Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol. 2018; 14(11):639-652. PMC: 6211654. DOI: 10.1038/s41582-018-0079-7. View

Venegas C, Kumar S, Franklin B, Dierkes T, Brinkschulte R, Tejera D . Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease. Nature. 2018; 552(7685):355-361. DOI: 10.1038/nature25158. View

10.

Luciunaite A, McManus R, Jankunec M, Racz I, Dansokho C, Dalgediene I . Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia. J Neurochem. 2019; 155(6):650-661. DOI: 10.1111/jnc.14945. View

11.

Leyns C, Ulrich J, Finn M, Stewart F, Koscal L, Remolina Serrano J . TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc Natl Acad Sci U S A. 2017; 114(43):11524-11529. PMC: 5663386. DOI: 10.1073/pnas.1710311114. View

12.

Selkoe D . Alzheimer disease and aducanumab: adjusting our approach. Nat Rev Neurol. 2019; 15(7):365-366. DOI: 10.1038/s41582-019-0205-1. View

13.

Novakovic D, Feligioni M, Scaccianoce S, Caruso A, Piccinin S, Schepisi C . Profile of gantenerumab and its potential in the treatment of Alzheimer's disease. Drug Des Devel Ther. 2013; 7:1359-64. PMC: 3832388. DOI: 10.2147/DDDT.S53401. View

14.

Dilena R, Mauri E, Aronica E, Bernasconi P, Bana C, Cappelletti C . Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome. Epilepsia Open. 2019; 4(2):344-350. PMC: 6546072. DOI: 10.1002/epi4.12317. View

15.

Mucke L, Selkoe D . Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med. 2012; 2(7):a006338. PMC: 3385944. DOI: 10.1101/cshperspect.a006338. View

16.

Selkoe D . Preventing Alzheimer's disease. Science. 2012; 337(6101):1488-92. DOI: 10.1126/science.1228541. View

17.

Halle A, Hornung V, Petzold G, Stewart C, Monks B, Reinheckel T . The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008; 9(8):857-65. PMC: 3101478. DOI: 10.1038/ni.1636. View

18.

Sheng J, Ito K, Skinner R, Mrak R, Rovnaghi C, Van Eldik L . In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging. 1996; 17(5):761-6. PMC: 3886636. DOI: 10.1016/0197-4580(96)00104-2. View

19.

Jiang C, Zou X, Zhu R, Shi Y, Wu Z, Zhao F . The correlation between accumulation of amyloid beta with enhanced neuroinflammation and cognitive impairment after intraventricular hemorrhage. J Neurosurg. 2018; 131(1):54-63. DOI: 10.3171/2018.1.JNS172938. View

20.

Hansen D, Hanson J, Sheng M . Microglia in Alzheimer's disease. J Cell Biol. 2017; 217(2):459-472. PMC: 5800817. DOI: 10.1083/jcb.201709069. View